ALFA FinderEvery NSE & BSE company
5,879 listed companies, ranked by market cap. Open any company to see every announcement it has filed: order wins, results, earnings calls, fund raises, board meetings and more.
Sector
All sectors
Banking and Finance 634Commercial Services & Supplies 606General Industrials 504Textiles Apparels & Accessories 476Software & Services 322Cement and Construction 266Metals & Mining 264Chemicals & Petrochemicals 262Pharmaceuticals & Biotechnology 235Food, Beverages & Tobacco 233Realty 224Automobiles & Auto Components 218Consumer Durables 188FMCG 142Transportation 139Diversified Consumer Services 131Utilities 118Media 113Healthcare 102Retailing 95Hotels Restaurants & Tourism 89Oil & Gas 45Others 40Fertilizers 31Hardware Technology & Equipment 28Diversified 26Telecommunications Equipment 21Forest Materials 20Telecom Services 20
| # | Company | Sector | Market cap | Announcements | Latest |
|---|---|---|---|---|---|
| 15 | Sun Pharmaceutical Industries LtdNSE: SUNPHARMA · BSE: 524715 | Pharmaceuticals & Biotechnology | ₹4,51,075 Cr | 72 | Price Movement Clarification2 Nov 2026 |
| 30 | Divi's Laboratories LtdNSE: DIVISLAB · BSE: 532488 | Pharmaceuticals & Biotechnology | ₹3,03,749 Cr | 27 | Earnings Call13 Nov 2026 |
| 53 | Torrent Pharmaceuticals LtdNSE: TORNTPHARM · BSE: 500420 | Pharmaceuticals & Biotechnology | ₹1,77,632 Cr | 46 | Debt & Borrowing9 Nov 2026 |
| 79 | Laurus Labs LtdNSE: LAURUSLABS · BSE: 540222 | Pharmaceuticals & Biotechnology | ₹1,30,972 Cr | 51 | Earnings Call29 Oct 2026 |
| 93 | Zydus Lifesciences LtdNSE: ZYDUSLIFE · BSE: 532321 | Pharmaceuticals & Biotechnology | ₹1,19,732 Cr | 90 | Merger & Restructuring12 Nov 2026 |
| 100 | Dr. Reddy's Laboratories LtdNSE: DRREDDY · BSE: 500124 | Pharmaceuticals & Biotechnology | ₹1,15,185 Cr | 58 | Regulatory Approval5 Nov 2026 |
| 105 | Cipla LtdNSE: CIPLA · BSE: 500087 | Pharmaceuticals & Biotechnology | ₹1,12,442 Cr | 54 | Management Change4 Nov 2026 |
| 110 | Mankind Pharma LtdNSE: MANKIND · BSE: 543904 | Pharmaceuticals & Biotechnology | ₹1,09,044 Cr | 66 | Other Announcement13 Nov 2026 |
| 114 | Aurobindo Pharma LtdNSE: AUROPHARMA · BSE: 524804 | Pharmaceuticals & Biotechnology | ₹1,05,892 Cr | 80 | Business Update11 Nov 2026 |
| 129 | Lupin LtdNSE: LUPIN · BSE: 500257 | Pharmaceuticals & Biotechnology | ₹90,558 Cr | 73 | Product Launch12 Nov 2026 |
| 150 | Glenmark Pharmaceuticals LtdNSE: GLENMARK · BSE: 532296 | Pharmaceuticals & Biotechnology | ₹74,507 Cr | 47 | Earnings Call6 Nov 2026 |
| 179 | Alkem Laboratories LtdNSE: ALKEM · BSE: 539523 | Pharmaceuticals & Biotechnology | ₹61,146 Cr | 60 | Earnings Call12 Nov 2026 |
| 184 | Biocon LtdNSE: BIOCON · BSE: 532523 | Pharmaceuticals & Biotechnology | ₹59,329 Cr | 69 | Earnings Call11 Nov 2026 |
| 191 | Abbott India LtdNSE: ABBOTINDIA · BSE: 500488 | Pharmaceuticals & Biotechnology | ₹56,183 Cr | 21 | Financial Results5 Nov 2026 |
| 196 | Gland Pharma LtdNSE: GLAND · BSE: 543245 | Pharmaceuticals & Biotechnology | ₹55,016 Cr | 62 | Debt & Borrowing12 Nov 2026 |
| 199 | Anthem Biosciences LtdNSE: ANTHEM · BSE: 544449 | Pharmaceuticals & Biotechnology | ₹52,769 Cr | 37 | Earnings Call4 Nov 2026 |
| 216 | Ipca Laboratories LtdNSE: IPCALAB · BSE: 524494 | Pharmaceuticals & Biotechnology | ₹47,798 Cr | 24 | Earnings Call6 Nov 2026 |
| 223 | GlaxoSmithKline Pharmaceuticals LtdNSE: GLAXO · BSE: 500660 | Pharmaceuticals & Biotechnology | ₹45,275 Cr | 42 | Earnings Call4 Nov 2026 |
| 226 | Emcure Pharmaceuticals LtdNSE: EMCURE · BSE: 544210 | Pharmaceuticals & Biotechnology | ₹44,804 Cr | 54 | Earnings Call3 Nov 2026 |
| 234 | Ajanta Pharma LtdNSE: AJANTPHARM · BSE: 532331 | Pharmaceuticals & Biotechnology | ₹41,037 Cr | 41 | Earnings Call30 Oct 2026 |
| 235 | Sai Life Science LtdNSE: SAILIFE · BSE: 544306 | Pharmaceuticals & Biotechnology | ₹41,003 Cr | 39 | Credit Rating13 Nov 2026 |
| 267 | Acutaas Chemicals LtdNSE: ACUTAAS · BSE: 543349 | Pharmaceuticals & Biotechnology | ₹33,069 Cr | 49 | Management Change2 Nov 2026 |
| 269 | Wockhardt LtdNSE: WOCKPHARMA · BSE: 532300 | Pharmaceuticals & Biotechnology | ₹32,944 Cr | 35 | Other Announcement2 Nov 2026 |
| 273 | Piramal Pharma LtdNSE: PPLPHARMA · BSE: 543635 | Pharmaceuticals & Biotechnology | ₹32,557 Cr | 43 | Capital Structure Change31 Oct 2026 |
| 305 | Rubicon Research LtdNSE: RUBICON · BSE: 544578 | Pharmaceuticals & Biotechnology | ₹27,763 Cr | 48 | Earnings Call5 Nov 2026 |
| 311 | Neuland Laboratories LtdNSE: NEULANDLAB · BSE: 524558 | Pharmaceuticals & Biotechnology | ₹27,043 Cr | 43 | Earnings Call3 Nov 2026 |
| 375 | Alembic Pharmaceuticals LtdNSE: APLLTD · BSE: 533573 | Pharmaceuticals & Biotechnology | ₹20,249 Cr | 80 | Regulatory Approval4 Nov 2026 |
| 377 | Granules India LtdNSE: GRANULES · BSE: 532482 | Pharmaceuticals & Biotechnology | ₹20,151 Cr | 56 | Earnings Call2 Nov 2026 |
| 383 | Shilpa Medicare LtdNSE: SHILPAMED · BSE: 530549 | Pharmaceuticals & Biotechnology | ₹19,392 Cr | 54 | Earnings Call5 Nov 2026 |
| 393 | OneSource Specialty Pharma LtdNSE: ONESOURCE · BSE: 544292 | Pharmaceuticals & Biotechnology | ₹18,464 Cr | 57 | Business Update30 Oct 2026 |
| 395 | Caplin Point Laboratories LtdNSE: CAPLIPOINT · BSE: 524742 | Pharmaceuticals & Biotechnology | ₹18,157 Cr | 29 | Earnings Call12 Nov 2026 |
| 396 | Eris Lifesciences LtdNSE: ERIS · BSE: 540596 | Pharmaceuticals & Biotechnology | ₹18,136 Cr | 48 | Annual General Meeting4 Nov 2026 |
| 400 | Alivus Life Sciences LtdNSE: ALIVUS · BSE: 543322 | Pharmaceuticals & Biotechnology | ₹17,961 Cr | 34 | Acquisition11 Nov 2026 |
| 401 | Syngene International LtdNSE: SYNGENE · BSE: 539268 | Pharmaceuticals & Biotechnology | ₹17,935 Cr | 45 | Earnings Call28 Oct 2026 |
| 406 | Pfizer LtdNSE: PFIZER · BSE: 500680 | Pharmaceuticals & Biotechnology | ₹17,601 Cr | 23 | Financial Results3 Nov 2026 |
| 409 | Cohance Lifesciences LtdNSE: COHANCE · BSE: 543064 | Pharmaceuticals & Biotechnology | ₹17,547 Cr | 47 | Capital Structure Change11 Nov 2026 |
| 447 | Natco Pharma LtdNSE: NATCOPHARM · BSE: 524816 | Pharmaceuticals & Biotechnology | ₹15,898 Cr | 53 | Earnings Call13 Nov 2026 |
| 463 | Jubilant Pharmova LtdNSE: JUBLPHARMA · BSE: 530019 | Pharmaceuticals & Biotechnology | ₹15,356 Cr | 42 | Results Update13 Nov 2026 |
| 470 | AstraZeneca Pharma India LtdNSE: ASTRAZEN · BSE: 506820 | Pharmaceuticals & Biotechnology | ₹15,079 Cr | 52 | Product Launch7 Nov 2026 |
| 488 | Marksans Pharma LtdNSE: MARKSANS · BSE: 524404 | Pharmaceuticals & Biotechnology | ₹14,435 Cr | 37 | Earnings Call5 Nov 2026 |
| 490 | Corona Remedies LtdNSE: CORONA · BSE: 544644 | Pharmaceuticals & Biotechnology | ₹14,248 Cr | 31 | Legal & Regulatory3 Nov 2026 |
| 508 | Sudeep Pharma LtdNSE: SUDEEPPHRM · BSE: 544619 | Pharmaceuticals & Biotechnology | ₹13,545 Cr | 27 | Earnings Call29 Oct 2026 |
| 538 | Concord Biotech LtdNSE: CONCORDBIO · BSE: 543960 | Pharmaceuticals & Biotechnology | ₹12,428 Cr | 36 | Other Announcement12 Nov 2026 |
| 557 | Akums Drugs & Pharmaceuticals LtdNSE: AKUMS · BSE: 544222 | Pharmaceuticals & Biotechnology | ₹11,664 Cr | 44 | Earnings Call3 Nov 2026 |
| 567 | Viyash Scientific LtdNSE: VIYASH · BSE: 512529 | Pharmaceuticals & Biotechnology | ₹11,285 Cr | 58 | Earnings Call13 Nov 2026 |
| 590 | Symbiotec Pharmalab LtdNSE: SYMBIOTEC · BSE: 544889 | Pharmaceuticals & Biotechnology | ₹10,354 Cr | 18 | Earnings Call6 Nov 2026 |
| 616 | Procter & Gamble Health LtdNSE: PGHL · BSE: 500126 | Pharmaceuticals & Biotechnology | ₹9,643 Cr | 26 | Other Announcement13 Nov 2026 |
| 624 | Blue Jet Healthcare LtdNSE: BLUEJET · BSE: 544009 | Pharmaceuticals & Biotechnology | ₹9,356 Cr | 36 | Partnership13 Nov 2026 |
| 625 | Strides Pharma Science LtdNSE: STAR · BSE: 532531 | Pharmaceuticals & Biotechnology | ₹9,353 Cr | 36 | Earnings Call2 Nov 2026 |
| 636 | Aarti Pharmalabs LtdNSE: AARTIPHARM · BSE: 543748 | Pharmaceuticals & Biotechnology | ₹9,049 Cr | 44 | Earnings Call29 Oct 2026 |
| 662 | Sanofi Consumer Healthcare India LtdNSE: SANOFICONR · BSE: 544250 | Pharmaceuticals & Biotechnology | ₹8,313 Cr | 21 | Annual General Meeting6 Nov 2026 |
| 689 | Sanofi India LtdNSE: SANOFI · BSE: 500674 | Pharmaceuticals & Biotechnology | ₹7,603 Cr | 40 | Other Announcement29 Oct 2026 |
| 720 | Bliss GVS Pharma LtdNSE: BLISSGVS · BSE: 506197 | Pharmaceuticals & Biotechnology | ₹7,161 Cr | 56 | Legal & Regulatory6 Nov 2026 |
| 743 | Innova Captab LtdNSE: INNOVACAP · BSE: 544067 | Pharmaceuticals & Biotechnology | ₹6,709 Cr | 40 | Earnings Call13 Nov 2026 |
| 746 | Sun Pharma Advanced Research Company LtdNSE: SPARC · BSE: 532872 | Pharmaceuticals & Biotechnology | ₹6,680 Cr | 30 | Promoter Reclassification12 Nov 2026 |
| 782 | FDC LtdNSE: FDC · BSE: 531599 | Pharmaceuticals & Biotechnology | ₹6,058 Cr | 36 | Legal & Regulatory5 Nov 2026 |
| 795 | IOL Chemicals and Pharmaceuticals LtdNSE: IOLCP · BSE: 524164 | Pharmaceuticals & Biotechnology | ₹5,918 Cr | 38 | Earnings Call5 Nov 2026 |
| 826 | Morepen Laboratories LtdNSE: MOREPENLAB · BSE: 500288 | Pharmaceuticals & Biotechnology | ₹5,460 Cr | 43 | Product Launch9 Nov 2026 |
| 830 | Senores Pharmaceuticals LtdNSE: SENORES · BSE: 544319 | Pharmaceuticals & Biotechnology | ₹5,409 Cr | 53 | Earnings Call29 Oct 2026 |
| 840 | Orchid Pharma LtdNSE: ORCHPHARMA · BSE: 524372 | Pharmaceuticals & Biotechnology | ₹5,296 Cr | 38 | Other Announcement13 Nov 2026 |
| 850 | Supriya Lifescience LtdNSE: SUPRIYA · BSE: 543434 | Pharmaceuticals & Biotechnology | ₹5,087 Cr | 36 | Earnings Call13 Nov 2026 |
| 851 | Gujarat Themis Biosyn LtdNSE: GUJTHEM · BSE: 506879 | Pharmaceuticals & Biotechnology | ₹5,058 Cr | 72 | Preferential Issue4 Nov 2026 |
| 854 | Evonile Pharma LtdNSE: NOVARTIND · BSE: 500672 | Pharmaceuticals & Biotechnology | ₹4,927 Cr | 49 | Annual General Meeting13 Nov 2026 |
| 870 | Gufic BioSciences LtdNSE: GUFICBIO · BSE: 509079 | Pharmaceuticals & Biotechnology | ₹4,744 Cr | 41 | Other Announcement13 Nov 2026 |
| 882 | Aarti Drugs LtdNSE: AARTIDRUGS · BSE: 524348 | Pharmaceuticals & Biotechnology | ₹4,631 Cr | 37 | Business Update6 Nov 2026 |
| 898 | SMS Pharmaceuticals LtdNSE: SMSPHARMA · BSE: 532815 | Pharmaceuticals & Biotechnology | ₹4,504 Cr | 37 | Other Announcement13 Nov 2026 |
| 901 | Zota Healthcare LtdNSE: ZOTA | Pharmaceuticals & Biotechnology | ₹4,492 Cr | 41 | Earnings Call29 Oct 2026 |
| 927 | Jeena Sikho Lifecare LtdNSE: JSLL · BSE: 544476 | Pharmaceuticals & Biotechnology | ₹4,253 Cr | 62 | Product Launch11 Nov 2026 |
| 930 | RPG Life Sciences LtdNSE: RPGLIFE · BSE: 532983 | Pharmaceuticals & Biotechnology | ₹4,220 Cr | 46 | Earnings Call30 Oct 2026 |
| 959 | Kwality Pharmaceuticals LtdNSE: KPL · BSE: 539997 | Pharmaceuticals & Biotechnology | ₹3,968 Cr | 28 | Management Change12 Nov 2026 |
| 991 | Shukra Pharmaceuticals LtdNSE: SHUKRAPHAR · BSE: 524632 | Pharmaceuticals & Biotechnology | ₹3,640 Cr | 36 | Preferential Issue7 Nov 2026 |
| 1006 | Unichem Laboratories LtdNSE: UNICHEMLAB · BSE: 506690 | Pharmaceuticals & Biotechnology | ₹3,511 Cr | 27 | Financial Results4 Nov 2026 |
| 1030 | Solara Active Pharma Sciences LtdNSE: SOLARA · BSE: 541540 | Pharmaceuticals & Biotechnology | ₹3,322 Cr | 36 | Other Announcement20 Oct 2026 |
| 1050 | Advanced Enzyme Technologies LtdNSE: ADVENZYMES · BSE: 540025 | Pharmaceuticals & Biotechnology | ₹3,176 Cr | 86 | Earnings Call3 Nov 2026 |
| 1052 | Ind-Swift Laboratories LtdNSE: INDSWFTLAB · BSE: 532305 | Pharmaceuticals & Biotechnology | ₹3,142 Cr | 50 | Earnings Call4 Nov 2026 |
| 1091 | Alembic LtdNSE: ALEMBICLTD · BSE: 506235 | Pharmaceuticals & Biotechnology | ₹2,914 Cr | 26 | Financial Results6 Nov 2026 |
| 1118 | Hikal LtdNSE: HIKAL · BSE: 524735 | Pharmaceuticals & Biotechnology | ₹2,743 Cr | 39 | Earnings Call3 Nov 2026 |
| 1122 | Dishman Carbogen Amcis LtdNSE: DCAL · BSE: 540701 | Pharmaceuticals & Biotechnology | ₹2,711 Cr | 53 | Financial Results13 Nov 2026 |
| 1196 | Sakar Healthcare LtdNSE: SAKAR | Pharmaceuticals & Biotechnology | ₹2,319 Cr | 30 | Earnings Call27 Oct 2026 |
| 1221 | Sai Parenterals LtdNSE: SAIPARENT · BSE: 544742 | Pharmaceuticals & Biotechnology | ₹2,195 Cr | 41 | Earnings Call2 Nov 2026 |
| 1231 | Panacea Biotec LtdNSE: PANACEABIO · BSE: 531349 | Pharmaceuticals & Biotechnology | ₹2,171 Cr | 31 | Board Meeting Date5 Nov 2026 |
| 1234 | Fredun Pharmaceuticals LtdNSE: FREDUN · BSE: 539730 | Pharmaceuticals & Biotechnology | ₹2,151 Cr | 39 | Financial Results5 Nov 2026 |
| 1237 | Indoco Remedies LtdNSE: INDOCO · BSE: 532612 | Pharmaceuticals & Biotechnology | ₹2,111 Cr | 46 | Promoter Buying12 Nov 2026 |
| 1240 | Windlas Biotech LtdNSE: WINDLAS · BSE: 543329 | Pharmaceuticals & Biotechnology | ₹2,102 Cr | 41 | Management Change5 Nov 2026 |
| 1267 | Beta Drugs LtdNSE: BETA · BSE: 531481 | Pharmaceuticals & Biotechnology | ₹2,015 Cr | 34 | Other Announcement12 Nov 2026 |
| 1270 | Venus Remedies LtdNSE: VENUSREM · BSE: 526953 | Pharmaceuticals & Biotechnology | ₹2,002 Cr | 27 | Other Announcement5 Nov 2026 |
| 1277 | Hester Biosciences LtdNSE: HESTERBIO · BSE: 524669 | Pharmaceuticals & Biotechnology | ₹1,977 Cr | 30 | Earnings Call7 Nov 2026 |
| 1297 | Syncom Formulation (India) LtdNSE: SYNCOMF · BSE: 524470 | Pharmaceuticals & Biotechnology | ₹1,907 Cr | 28 | Financial Results13 Nov 2026 |
| 1302 | NGL Fine - Chem LtdNSE: NGLFINE · BSE: 524774 | Pharmaceuticals & Biotechnology | ₹1,879 Cr | 29 | Earnings Call12 Nov 2026 |
| 1424 | Accent Microcell LtdNSE: ACCENTMIC | Pharmaceuticals & Biotechnology | ₹1,473 Cr | 22 | Financial Results14 Oct 2026 |
| 1426 | Amrutanjan Health Care LtdNSE: AMRUTANJAN · BSE: 590006 | Pharmaceuticals & Biotechnology | ₹1,470 Cr | 38 | Earnings Call3 Nov 2026 |
| 1429 | Bharat Parenterals LtdNSE: BPLPHARMA · BSE: 541096 | Pharmaceuticals & Biotechnology | ₹1,465 Cr | 38 | Earnings Call2 Nov 2026 |
| 1439 | Jagsonpal Pharmaceuticals LtdNSE: JAGSNPHARM · BSE: 507789 | Pharmaceuticals & Biotechnology | ₹1,426 Cr | 53 | Earnings Call28 Oct 2026 |
| 1447 | Kopran LtdNSE: KOPRAN · BSE: 524280 | Pharmaceuticals & Biotechnology | ₹1,397 Cr | 36 | Price Movement Clarification13 Nov 2026 |
| 1449 | Fermenta Biotech LtdNSE: FERMENTA · BSE: 506414 | Pharmaceuticals & Biotechnology | ₹1,394 Cr | 36 | Results Update5 Nov 2026 |
| 1544 | Bafna Pharmaceuticals LtdNSE: BAFNAPH · BSE: 532989 | Pharmaceuticals & Biotechnology | ₹1,140 Cr | 13 | Financial Results11 Nov 2026 |
| 1568 | Bajaj Healthcare LtdNSE: BAJAJHCARE · BSE: 539872 | Pharmaceuticals & Biotechnology | ₹1,089 Cr | 38 | Earnings Call19 Oct 2026 |
| 1569 | Sigachi Industries LtdNSE: SIGACHI · BSE: 543389 | Pharmaceuticals & Biotechnology | ₹1,088 Cr | 37 | Other Announcement12 Nov 2026 |
| 1584 | Lincoln Pharmaceuticals LtdNSE: LINCOLN · BSE: 531633 | Pharmaceuticals & Biotechnology | ₹1,046 Cr | 21 | Financial Results29 Oct 2026 |
| 1617 | Vikram Thermo (India) LtdNSE: VIKRAMTH · BSE: 530477 | Pharmaceuticals & Biotechnology | ₹1,004 Cr | 22 | Financial Results4 Nov 2026 |